KalVista Pharmaceuticals, Inc.
KALV
46 insider filings · Latest: Jun 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 10 10:47 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 6,693 | $16.08 | $107.6K | 451,815(D) | View → |
| Feb 23, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 5,354 | $15.57 | $83.3K | 138,983(D) | View → |
| Feb 23, 2026 | Feb 25 12:44 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 10,034 | $15.57 | $156.2K | 442,883(D) | View → |
| Feb 23, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 4,347 | $15.57 | $67.7K | 226,701(D) | View → |
| Feb 23, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Sale | 3,975 | $15.57 | $61.9K | 47,003(D) | View → |
| Feb 23, 2026 | Feb 25 12:42 AM | Brian PiekosChief Financial Officer | Sale | 1,767 | $15.57 | $27.5K | 13,762(D) | View → |
| Feb 18, 2026 | Feb 20 12:45 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 1,038 | $15.00 | $15.6K | 429,667(D) | View → |
| Feb 18, 2026 | Feb 20 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 1,163 | $15.00 | $17.4K | 133,087(D) | View → |
| Feb 18, 2026 | Feb 20 12:44 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 1,109 | $15.00 | $16.6K | 224,173(D) | View → |
| Feb 12, 2026 | Feb 13 9:05 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 3,354 | $15.70 | $52.7K | 428,286(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 20 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 2,419 | — | 2,419(D) | View → |
| Feb 17, 2026 | Feb 20 12:44 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 1,774 | — | 1,774(D) | View → |
| Feb 11, 2026 | Feb 13 9:05 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 7,120 | — | 99,680(D) | View → |
| Jan 16, 2026 | Jan 21 9:11 PM | Bilal ArifChief Operations Officer | Grant/Award | 49,000 | — | 49,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:11 PM | Nicole SweenyChief Commercial Officer | Grant/Award | 100,000 | — | 100,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:10 PM | Brian PiekosChief Financial Officer | Grant/Award | 100,000 | — | 100,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:10 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Grant/Award | 100,000 | — | 100,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:09 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 325,000 | — | 325,000(D) | View → |
← Previous
Page 3 of 3